Key Insights

Highlights

Success Rate

84% trial completion

Published Results

32 trials with published results (9%)

Research Maturity

175 completed trials (51% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

9.9%

34 terminated out of 345 trials

Success Rate

83.7%

-2.8% vs benchmark

Late-Stage Pipeline

10%

33 trials in Phase 3/4

Results Transparency

18%

32 of 175 completed with results

Key Signals

32 with results84% success34 terminated

Data Visualizations

Phase Distribution

168Total
Not Applicable (60)
Early P 1 (2)
P 1 (20)
P 2 (53)
P 3 (24)
P 4 (9)

Trial Status

Completed175
Unknown87
Terminated34
Withdrawn27
Recruiting13
Active Not Recruiting4

Trial Success Rate

83.7%

Benchmark: 86.5%

Based on 175 completed trials

Clinical Trials (345)

Showing 20 of 20 trials
NCT04362150RecruitingPrimary

Long-term Impact of Infection With Novel Coronavirus (COVID-19)

NCT04910269Phase 3SuspendedPrimary

Outpatient Treatment With Anti-Coronavirus Immunoglobulin

NCT06692400Not ApplicableRecruiting

The Effects of Endotracheal Suctioning on Pain and Serum Markers

NCT04344119Recruiting

Assessment of Chilbains Occuring During Covid-19 Infection

NCT06821139Completed

Cohort Study of Intraoperative Lung Protective Ventilation Trends in a Large Canadian Health Authority

NCT04401111Active Not RecruitingPrimary

One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)

NCT04568148Active Not Recruiting

COVID-19 Biorepository

NCT03590327Not ApplicableCompleted

Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment

NCT05137795Phase 3Withdrawn

Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19

NCT04447833Phase 1Completed

Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome

NCT04367545Not ApplicableCompletedPrimary

Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic

NCT04382131Not ApplicableTerminated

Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19)

NCT04407143Completed

Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection

NCT04394390CompletedPrimary

Vitamin D Levels in SARS-CoV-2: Do Current Adequacy Thresholds Reflect Clinical Risk? Insights From a Large Turkish Cohort

NCT04395599Not ApplicableCompleted

Risk of Air Contamination During Visceral Surgery in COVID19 Patients

NCT04411602Phase 1Withdrawn

Intermediate IND Severe Illness COVID-19 CP

NCT04425616Not ApplicableCompleted

SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer

NCT03452774Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT07221097Recruiting

Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses

NCT06744660Not ApplicableRecruiting

Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test

Scroll to load more

Research Network

Activity Timeline